Contextualizing Research Processes
Private Sector Engagement
Private Section Engagement on RUTFs at the Presidential Villa
Dr Obi Adigwe, DG NIPRD presenting ASICC-19 documents to Vice President, Prof. Yemi Osinbajo
Dr Adigwe presenting a Business Feasibility Plan on CPP to the Kaduna State Government
NIPRD Laboratory Complex
Head office of the National Institute for Pharmaceutical Research and Development
Prof Yemi Osinbajo with Dr. John Alfa and Dr. Obi Adigwe shortly after declaring the All-stakeholders'Int'l Conference on COVID-19 (ASICC-19) open
Chief Diana Chen, Chair CABC Collaborative Visit to DG NIPRD
Robust Inter-governmental Agency Collaboration
NIPRD signs MoU with FMSDIGA and NLTF on CPPInternational Conference on Health Access and Socio-Economic Development Beyond COVID-19 (ASICC-19)Webinar Conference (Series 3.0) on “Improving Access to COVID-19 Vaccines and other Interventions: Intellectual Property, Patent Waivers and other Critical Factors” PRESS RELEASESCommunity Engagement with the Jiwa ChiefdomMinisterial Health Sector Media Engagement
Welcome message from the Director-General / CEO
The National Institute for Pharmaceutical Research and Development (NIPRD) is a Federal Government Parastatal under the Federal Ministry of Health. The Agency was established by Government Order No. 33 Vol. 74 of 11th June 1987 Part B under the Science and Technology Act Cap 276. It became functional in the year 1989. In 2001 following a Federal Executive Council decision, NIPRD was moved to the Federal Ministry of Health (FMOH), with a huge investment in scientific equipment and human resources.
NIPRD is the only one of its kind in the Region, and is statutorily charged with the responsibility for research and development of drugs, vaccines, phytomedicines, commodities, and diagnostics aimed at improving sustainable access to safe, affordable and high-quality healthcare. Read more…
Latest Media Engagement
"NIPRD is taking the lead, especially with innovative concepts like the CPP project"
"NIPRD intervention leverages the systems approach to ensure that while its projects improve access to health, it also makes significant impact on relevant socioeconomic variables"
"At no time in our Nation’s history is NIPRD relevant more than now when President Muhammadu Buhari is determined to implement Universal Health Coverage for our people."
NSP-II and M&E Plan (2021 - 2025)
Follow NIPRD on TwitterMy Tweets
NIPRD signs MoU with FMSDIGA and NLTF on CPP
MoU Signing between NIPRD, FMSDIGA and NLTF on Contextual Processing Protocol (CCP) for Harnessing Nigerian Natural Resources The Federal Government and the National Institute for
International Conference on Health Access and Socio-Economic Development Beyond COVID-19 (ASICC-19)
ASICC-19 Opening Presidential Statement Opening – 18th October, 2021 Nigeria Has What It Takes To Become A Leader In Healthcare, Says Osinbajo Know more… Nigeria,
Webinar Conference (Series 3.0) on “Improving Access to COVID-19 Vaccines and other Interventions: Intellectual Property, Patent Waivers and other Critical Factors” PRESS RELEASES
Express Day Nigeria can lead vaccines production in Africa- NIPRD DG Independent Nigeria Can Lead Vaccines Production In Africa – NIPRD DG Vanguard With right
Community Engagement with the Jiwa Chiefdom
Dr. Obi Adigwe, Director General, NIPRD with HRH the Emir of Jiwa Chiefdom, Dr. Alh. Musa Idrisu Charting path for continued mutual coexistence Dr. Obi